30 Day Trial

About ORTHOWORLD

Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.

ORTHOFLASH Subscribe

06/26/2017
  • 11:00 a.m. Bone Therapeutics received notice that the European Patent Office will grant the company a patent covering its allogeneic cell therapy technology
  • Paragon 28 launched the PHANTOM™ Lapidus Intramedullary Nail, the first dedicated intramedullary nail used to correct arthrodesis of the first TMT joint. 
 
06/22/2017
  • 3:00 p.m. K2M announced FDA 510(k) clearance of MOJAVEPL, a 3D-printed expandable posterior lumbar interbody system featuring Lamellar 3D Titanium™.
Read More

Articles of Interest All Articles

Tools to Achieve Your 2017 Priorities

“Become a more diverse provider.” This 2017 market opportunity was a resounding response from device and supplier company leaders whom we surveyed in 2016. Almost halfway through 2017, it’s important to identify the tools and expertise needed for the next seven months to satisfy your company’s diversification commitments.